These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8730126)

  • 1. Regulation of alkaline phosphatase: implications for calcium pyrophosphate dihydrate crystal dissolution and other alkaline phosphatase functions.
    Shinozaki T; Pritzker KP
    J Rheumatol; 1996 Apr; 23(4):677-83. PubMed ID: 8730126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyamines enhance calcium pyrophosphate dihydrate crystal dissolution.
    Shinozaki T; Pritzker KP
    J Rheumatol; 1995 Oct; 22(10):1907-12. PubMed ID: 8991990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkaline phosphatase dissolves calcium pyrophosphate dihydrate crystals.
    Xu Y; Cruz TF; Pritzker KP
    J Rheumatol; 1991 Oct; 18(10):1606-10. PubMed ID: 1765989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease.
    So PP; Tsui FW; Vieth R; Tupy JH; Pritzker KP
    J Rheumatol; 2007 Jun; 34(6):1313-22. PubMed ID: 17516619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implications of alkaline phosphatase pyrophosphatase activity: intracellular functions of alkaline phosphatase].
    Shinozaki T; Pritzker KP
    Nihon Seikeigeka Gakkai Zasshi; 1994 Jul; 68(7):545-51. PubMed ID: 8071580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium pyrophosphate dihydrate (CPPD) crystal dissolution by alkaline phosphatase: interaction of alkaline phosphatase on CPPD crystals.
    Shinozaki T; Xu Y; Cruz TF; Pritzker KP
    J Rheumatol; 1995 Jan; 22(1):117-23. PubMed ID: 7699658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mercaptopyruvate inhibits tissue-nonspecific alkaline phosphatase and calcium pyrophosphate dihydrate crystal dissolution.
    Kannampuzha JV; Tupy JH; Pritzker KP
    J Rheumatol; 2009 Dec; 36(12):2758-65. PubMed ID: 19884277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pyrophosphatase on dissolution of calcium pyrophosphate dihydrate crystals.
    Xu Y; Cruz T; Cheng PT; Pritzker KP
    J Rheumatol; 1991 Jan; 18(1):66-71. PubMed ID: 1850802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of chondrocyte alkaline phosphatase as a potential mediator in the dissolution of calcium pyrophosphate dihydrate crystals.
    Xu Y; Pritzker KP; Cruz TF
    J Rheumatol; 1994 May; 21(5):912-9. PubMed ID: 8064734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions.
    Cheng PT; Pritzker KP
    J Rheumatol; 1983 Oct; 10(5):769-77. PubMed ID: 6315937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferrous [Fe++] but not ferric [Fe] ions inhibit de novo formation of calcium pyrophosphate dihydrate crystals: possible relationships to chondrocalcinosis and hemochromatosis.
    Cheng PT; Pritzker KP
    J Rheumatol; 1988 Feb; 15(2):321-4. PubMed ID: 2834554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The solubility of calcium pyrophosphate dihydrate crystals].
    Sakamoto H
    Nihon Seikeigeka Gakkai Zasshi; 1995 Jul; 69(7):484-92. PubMed ID: 7561350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
    Hirose J; Ryan LM; Masuda I
    Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of [(3)H]MPP(+) transport by phosphorylation/dephosphorylation pathways in RBE4 cells: role of ecto-alkaline phosphatase.
    Calhau C; Martel F; Soares-da-Silva P; Hipólito-Reis C; Azevedo I
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):349-56. PubMed ID: 12012020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of low density lipoprotein on the inflammation-inducing activity of calcium pyrophosphate dihydrate crystals.
    Kumagai Y; Watanabe W; Kobayashi A; Sato K; Onuma S; Sakamoto H
    J Rheumatol; 2001 Dec; 28(12):2674-80. PubMed ID: 11764217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium pyrophosphate crystal deposition: a kinetic study using a type I collagen gel model.
    Mandel GS; Halverson PB; Rathburn M; Mandel NS
    Scanning Microsc; 1990 Mar; 4(1):175-9; discussion 179-80. PubMed ID: 2164257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histochemical localization of calcium with potassium pyroantimonate in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
    Ohira T; Ishikawa K
    Clin Orthop Relat Res; 1991 Mar; (264):286-94. PubMed ID: 1705190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium pyrophosphate crystal deposition in hyaline cartilage. Ultrastructural analysis and implications for pathogenesis.
    Pritzker KP; Cheng PT; Renlund RC
    J Rheumatol; 1988; 15(5):828-35. PubMed ID: 2845077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium pyrophosphate crystal formation in aqueous solutions.
    Cheng PT; Pritzker KP; Adams ME; Nyburg SC; Omar SA
    J Rheumatol; 1980; 7(5):609-16. PubMed ID: 6255159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of alizarin red s staining in calcium pyrophosphate dihydrate crystal deposition disease.
    Yamakawa K; Iwasaki H; Masuda I; Ohjimi Y; Honda I; Saeki K; Zhang J; Shono E; Naito M; Kikuchi M
    J Rheumatol; 2003 May; 30(5):1032-5. PubMed ID: 12734902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.